Clinical Trials

Leukemia and Lymphoma

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 5 of 5 Clinical Trials Related to Leukemia and Lymphoma

Clinical Research Trial

SWOG S1925 Lymphoma

Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

Abbvie M23-362 Lymphoma

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Doctor(s) Running This Study
Bradley W. Lash, MD
Clinical Research Trial

EA9161 Chronic Lymphocytic Leukemia (CLL)

EA9161, “A Randomized Phase III Study of the addition of Venetoclax to Ibrutinib and Obinutuzumab versus Ibrutinib and Obinutuzumab in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

MSK 16-024 Leukemia

Observational Study to Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Newly Diagnosed and Relapsed Acute Leukemia

Doctor(s) Running This Study
Don J. Park, MD, PhD
Clinical Research Trial

A041501 Leukemia

A PHASE III TRIAL TO EVALUATE THE EFFICACY OF THE ADDITION OF INOTUZUMAB OZOGAMICIN (A CONJUGATED ANTI-CD22 MONOCLONAL ANTIBODY) TO FRONTLINE THERAPY IN YOUNG ADULTS (AGES 18-39 YEARS) WITH NEWLY

Doctor(s) Running This Study
Maged F. Khalil, MD